A clinical research facility that serves pharmaceutical and biotechnology firms and provides early clinical development, bio-analytical and late-stage clinical development services depends on Ultra-Scan’s LUIS^® technology to identify subjects participating in Phase I drug trials. 

The subject population for this facility consists of individuals representing widely diverse demographics, and the clinic employs attending staff with varying skill sets that assist with recruiting, enrollment and admissions.  The combination of these factors require the clinic to closely monitor the identity management system to ensure subject and staff activities are not contributing to performance degradation. 

Ultra-Scan utilizes remote database access to monitor the status of the AFIS server and analyze system performance on a monthly basis to provide the clinic with comprehensive IV&V reporting that ensures optimum system operation and supplies valuable data regarding the daily operation of the clinic.